Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes
This work is licensed under the Creative Commons Attribution 4.0 International License.
Mehta P, McAuley D, Brown M, Sanchez E, Tattersall R, Manson J, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England). 2020;395(10229):1033.MehtaPMcAuleyDBrownMSanchezETattersallRMansonJet alCOVID-19: consider cytokine storm syndromes and immunosuppression202039510229103310.1016/S0140-6736(20)30628-0727004532192578Search in Google Scholar
Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. Hypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. Journal of Thrombosis and Haemostasis. 2020;18(7):1738-42.PanigadaMBottinoNTagliabuePGrasselliGNovembrinoCChantarangkulVet alHypercoagulability of COVID‐19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis202018717384210.1111/jth.1485032302438Search in Google Scholar
Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575-e82.GoshuaGPineABMeizlishMLChangCHZhangHBahelPet alEndotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study202078e575e8210.1016/S2352-3026(20)30216-7732644632619411Search in Google Scholar
Wang L, Zhao L, Li F, Liu J, Zhang L, Li Q, Gu J, Liang S, Zhao Q, Liu J, Xu JF. Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients. The Clinical Respiratory Journal. 2022 Mar;16(3):182-9..WangLZhaoLLiFLiuJZhangLLiQGuJLiangSZhaoQLiuJXuJFRisk assessment of venous thromboembolism and bleeding in COVID‐19 patients2022Mar163182910.1111/crj.13467906001135060325Search in Google Scholar
Klok FA, Kruip MJ, Van der Meer NJ, Arbous MS, Gommers DA, Kant KM, Kaptein FH, van Paassen J, Stals MA, Huisman MV, Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis research. 2020 Jul 1;191:145-7.KlokFAKruipMJVander Meer NJArbousMSGommersDAKantKMKapteinFHvanPaassen JStalsMAHuismanMVEndemanHIncidence of thrombotic complications in critically ill ICU patients with COVID-192020Jul 1191145710.1016/j.thromres.2020.04.013714671432291094Search in Google Scholar
Tavazzi G, Civardi L, Caneva L, Mongodi S, Mojoli F. Thrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening. Intensive Care Medicine. 2020 Jun;46(6):1121-3.TavazziGCivardiLCanevaLMongodiSMojoliFThrombotic events in SARS-CoV-2 patients: an urgent call for ultrasound screening2020Jun4661121310.1007/s00134-020-06040-3717544932322918Search in Google Scholar
Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis research. 2020 Jul 1;191:9-14.LodigianiCIapichinoGCarenzoLCecconiMFerrazziPSebastianTKucherNStudtJDSaccoCBertuzziASandriMTVenous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy2020Jul 119191410.1016/j.thromres.2020.04.024717707032353746Search in Google Scholar
Grillet F, Behr J, Calame P, Aubry S, Delabrousse E. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography. Radiology. 2020:201544.GrilletFBehrJCalamePAubrySDelabrousseEAcute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography202020154410.1148/radiol.2020201544723338432324103Search in Google Scholar
Maatman TK, Jalali F, Feizpour C, Douglas 2nd A, McGuire SP, Kinnaman G, Hartwell JL, Maatman BT, Kreutz RP, Kapoor R, Rahman O. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019. Critical Care Medicine. 2020 Sep 1;48(9):e783-90.MaatmanTKJalaliFFeizpourCDouglas2nd AMcGuireSPKinnamanGHartwellJLMaatmanBTKreutzRPKapoorRRahmanORoutine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 20192020Sep 1489e7839010.1097/CCM.0000000000004466730208532459672Search in Google Scholar
Jiménez D, García-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, Le Mao R, Rodríguez C, Hunt BJ, Monreal M. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest. 2021 Mar;159(3):1182-1196.JiménezDGarcía-SanchezARaliPMurielABikdeliBRuiz-ArtachoPLeMao RRodríguezCHuntBJMonrealMIncidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis2021Mar;15931182119610.1016/j.chest.2020.11.005767088933217420Search in Google Scholar
Kaplan D, Casper TC, Elliott CG, Men S, Pendleton RC, Kraiss LW, et al. VTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock. Chest. 2015;148(5):1224.KaplanDCasperTCElliottCGMenSPendletonRCKraissLWet alVTE Incidence and Risk Factors in Patients With Severe Sepsis and Septic Shock20151485122410.1378/chest.15-0287463103826111103Search in Google Scholar
Wang J, Hajizadeh N, Moore EE, McIntyre RC, Moore PK, Veress LA, Yaffe MB, Moore HB, Barrett CD. Tissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): a case series. Journal of thrombosis and haemostasis. 2020 Jul;18(7):1752-5.WangJHajizadehNMooreEEMcIntyreRCMoorePKVeressLAYaffeMBMooreHBBarrettCDTissue plasminogen activator (tPA) treatment for COVID‐19 associated acute respiratory distress syndrome (ARDS): a case series2020Jul1871752510.1111/jth.14828726215232267998Search in Google Scholar
Campbell CM, Kahwash R. Will complement inhibition be the new target in treating COVID-19–related systemic thrombosis?. Circulation. 2020 Jun 2;141(22):1739-41.CampbellCMKahwashRWill complement inhibition be the new target in treating COVID-19–related systemic thrombosis?2020Jun 21412217394110.1161/CIRCULATIONAHA.120.04741932271624Search in Google Scholar
Casini A, Alberio L, Angelillo-Scherrer A, Fontana P, Gerber B, Graf L, et al. Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis. Swiss medical weekly. 2020;150:w20247.CasiniAAlberioLAngelillo-ScherrerAFontanaPGerberBGrafLet alThromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19-a Swiss consensus statement by the Working Party Hemostasis2020150w2024710.4414/smw.2020.2024732277760Search in Google Scholar
Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of thrombosis and haemostasis. 2020 May;18(5):1094-9.TangNBaiHChenXGongJLiDSunZAnticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy2020May1851094910.1111/jth.1481732220112Search in Google Scholar
Rentsch CT, Beckman JA, Tomlinson L, Gellad WF, Alcorn C, Kidwai-Khan F, et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ (Clinical research ed). 2021;372:n311.RentschCTBeckmanJATomlinsonLGelladWFAlcornCKidwai-KhanFet alEarly initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study2021372n31110.1136/bmj.n311787667233574135Search in Google Scholar
Carallo C, Pugliese F, Vettorato E, Tripolino C, Delle Donne L, Guarrera G, et al. Higher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia. Journal of Investigative Medicine. 2021;69(4):8847.CaralloCPuglieseFVettoratoETripolinoCDelleDonne LGuarreraGet alHigher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia2021694884710.1136/jim-2020-00162833758036Search in Google Scholar
Meizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, et al. Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysis. American journal of hematology. 2021;96(4):471-9.MeizlishMLGoshuaGLiuYFineRAminKChangEet alIntermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysis2021964471910.1002/ajh.26102801358833476420Search in Google Scholar
Al-Samkari H, Gupta S, Leaf RK, Wang W, Rosovsky RP, Brenner SK, et al. Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19. Annals of internal medicine. 2021;174(5):622-32.Al-SamkariHGuptaSLeafRKWangWRosovskyRPBrennerSKet alThrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19202117456223210.7326/M20-6739786367933493012Search in Google Scholar
Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, Mignatti A, Gianos E, Cohen M, Sharifova G, Lund JM. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. JAMA internal medicine. 2021 Dec 1;181(12):1612-20.SpyropoulosACGoldinMGiannisDDiabWWangJKhanijoSMignattiAGianosECohenMSharifovaGLundJMEfficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial2021Dec 11811216122010.1001/jamainternmed.2021.6203849893434617959Search in Google Scholar
Goligher EC, Bradbury CA, McVerry BJ, Lawler PR, Berger JS, Gong MN, Carrier M, Reynolds HR, Kumar A, Turgeon AF, Kornblith LZ. Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. The New England Journal of Medicine. 2021 Aug 4;385(9):777-89.GoligherECBradburyCAMcVerryBJLawlerPRBergerJSGongMNCarrierMReynoldsHRKumarATurgeonAFKornblithLZTherapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-192021Aug 438597778910.1056/NEJMoa2103417836259234351722Search in Google Scholar
Mazloomzadeh S, Khaleghparast S, Ghadrdoost B, Mousavizadeh M, Baay MR, Noohi F, Sharifnia H, Ahmadi A, Tavan S, Alamdari NM, Fathi M. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. Jama. 2021 Apr 27;325(16):1620-30.MazloomzadehSKhaleghparastSGhadrdoostBMousavizadehMBaayMRNoohiFSharifniaHAhmadiATavanSAlamdariNMFathiMEffect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial2021Apr 273251616203010.1001/jama.2021.4152797483533734299Search in Google Scholar
Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I. Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother. 2012;46(7-8):952-9.GrootaertVWillemsLDebaveyeYMeyfroidtGSprietIAugmented renal clearance in the critically ill: how to assess kidney function2012467-8952910.1345/aph.1Q70822693271Search in Google Scholar
National Institutes of Health. Clinical spectrum of SARS-CoV-2 infection. 2020. Available at: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. Accessed on December 20.National Institutes of Health2020Available athttps://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/.Accessed on December 20Search in Google Scholar
Schünemann HJ, Cushman M, Burnett AE, Kahn SR, Beyer-Westendorf J, Spencer FA, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients. Blood advances. 2018;2(22):3198-225.SchünemannHJCushmanMBurnettAEKahnSRBeyer-WestendorfJSpencerFAet alAmerican Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients2018222319822510.1182/bloodadvances.2018022954625891030482763Search in Google Scholar
Cohoon KP, Mahé G, Tafur AJ, Spyropoulos AC. Emergence of institutional antithrombotic protocols for coronavirus 2019. Research and Practice in Thrombosis and Haemostasis. 2020;4(4):510.CohoonKPMahéGTafurAJSpyropoulosACEmergence of institutional antithrombotic protocols for coronavirus 201920204451010.1002/rth2.12358726752432542211Search in Google Scholar
Meyer G, Planquette B. Incidental venous thromboembolism, detected by chance, but still venous thromboembolism. Eur Respiratory Soc; 2020.MeyerGPlanquetteBIncidental venous thromboembolism, detected by chance, but still venous thromboembolism202010.1183/13993003.00028-202032029648Search in Google Scholar
Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32-5.YoudenWJIndex for rating diagnostic tests19503132510.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3Search in Google Scholar
Kucher N, Kohler HP, Dornhöfer T, Wallmann D, Lämmle B. Accuracy of d‐dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study. Journal of Thrombosis and Haemostasis. 2003;1(4):708-13.KucherNKohlerHPDornhöferTWallmannDLämmleBAccuracy of d‐dimer/fibrinogen ratio to predict pulmonary embolism: a prospective diagnostic study2003147081310.1046/j.1538-7836.2003.00145.xSearch in Google Scholar
Yockey RD. SPSS demystified: A simple guide and reference: Routledge; 2016.YockeyRDRoutledge201610.4324/9781315508535Search in Google Scholar
Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis. 2020 Apr;18(4):844-7.TangNLiDWangXSunZAbnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia2020Apr184844710.1111/jth.14768Search in Google Scholar
Mousavi S, Moradi M, Khorshidahmad T, Motamedi M. Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review. Advances in Pharmacological Sciences. 2015 May 12;2015:507151-.MousaviSMoradiMKhorshidahmadTMotamediMAnti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review2015May 12201550715110.1155/2015/507151444364426064103Search in Google Scholar
Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Nigoghossian CD, Ageno W, Madjid M, Guo Y, Tang LV. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American college of cardiology. 2020 Jun 16;75(23):2950-73.BikdeliBMadhavanMVJimenezDChuichTDreyfusIDrigginENigoghossianCDAgenoWMadjidMGuoYTangLVCOVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review2020Jun 16752329507310.1016/j.jacc.2020.04.031716488132311448Search in Google Scholar
Masias C, Vasu S, Cataland S. None of the above: thrombotic microangiopathy beyond TTP and HUS. Blood. 2017;129(21):2857.MasiasCVasuSCatalandSNone of the above: thrombotic microangiopathy beyond TTP and HUS201712921285710.1182/blood-2016-11-74310428416509Search in Google Scholar
Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. Journal of the American College of Cardiology. 2020;76(16):1815-26.NadkarniGNLalaABagiellaEChangHLMorenoPRPujadasEet alAnticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-192020761618152610.1016/j.jacc.2020.08.041744965532860872Search in Google Scholar
Robinson S, Zincuk A, Strøm T, Larsen TB, Rasmussen B, Toft P. Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial. Critical Care. 2010;14(2):1-7.RobinsonSZincukAStrømTLarsenTBRasmussenBToftPEnoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial20101421710.1186/cc8924288715120298591Search in Google Scholar
Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials. Journal of Thrombosis and Haemostasis. 2016 Mar;14(3):518-30.UmemuraYYamakawaKOguraHYuharaHFujimiSEfficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials2016Mar1435183010.1111/jth.1323026670422Search in Google Scholar
Mattioli M, Benfaremo D, Mancini M, Mucci L, Mainquà P, Polenta A, et al. Safety of intermediate dose of low molecular weight heparin in COVID-19 patients. Journal of thrombosis and thrombolysis. 2021;51(2):286-92.MattioliMBenfaremoDManciniMMucciLMainquàPPolentaAet alSafety of intermediate dose of low molecular weight heparin in COVID-19 patients20215122869210.1007/s11239-020-02243-z742600732794132Search in Google Scholar
Arabi YM, Al-Hameed F, Burns KE, Mehta S, Alsolamy SJ, Alshahrani MS, et al. Adjunctive intermittent pneumatic compression for venous thromboprophylaxis. New England Journal of Medicine. 2019;380(14):1305-15.ArabiYMAl-HameedFBurnsKEMehtaSAlsolamySJAlshahraniMSet alAdjunctive intermittent pneumatic compression for venous thromboprophylaxis20193801413051510.1056/NEJMoa181615030779530Search in Google Scholar